Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...

The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...

In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...

Paratek Pharmaceuticals to acquire Optinose and its nasal drug-device Xhance for up to $330M, expanding beyond antibiotics ...

The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...

Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Some 30,000 fewer people are dying every year in the U.S. from fentanyl and other street drugs. This shift has stunned ...

Aquestive Therapeutics leverages its PharmFilm technology to develop innovative oral drug delivery systems. Find out why I'm neutral on AQST stock.

The teenage apprentice placed an online order for a pill he hoped would help him relax and get to sleep. He never woke up.